273 related articles for article (PubMed ID: 34622396)
1. Efficacy and Safety of Non-brain Penetrating H
Yanai K; Yoshikawa T; Church MK
Curr Top Behav Neurosci; 2022; 59():193-214. PubMed ID: 34622396
[TBL] [Abstract][Full Text] [Related]
2. Safety considerations in the management of allergic diseases: focus on antihistamines.
Yanai K; Rogala B; Chugh K; Paraskakis E; Pampura AN; Boev R
Curr Med Res Opin; 2012 Apr; 28(4):623-42. PubMed ID: 22455874
[TBL] [Abstract][Full Text] [Related]
3. Antihistamines for Allergic Rhinitis Treatment from the Viewpoint of Nonsedative Properties.
Kawauchi H; Yanai K; Wang DY; Itahashi K; Okubo K
Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30626077
[TBL] [Abstract][Full Text] [Related]
4. The clinical pharmacology of non-sedating antihistamines.
Yanai K; Yoshikawa T; Yanai A; Nakamura T; Iida T; Leurs R; Tashiro M
Pharmacol Ther; 2017 Oct; 178():148-156. PubMed ID: 28457804
[TBL] [Abstract][Full Text] [Related]
5. Brain histamine H1 receptor occupancy of loratadine measured by positron emission topography: comparison of H1 receptor occupancy and proportional impairment ratio.
Kubo N; Senda M; Ohsumi Y; Sakamoto S; Matsumoto K; Tashiro M; Okamura N; Yanai K
Hum Psychopharmacol; 2011 Mar; 26(2):133-9. PubMed ID: 21433074
[TBL] [Abstract][Full Text] [Related]
6. Clinical comparison of histamine H1-receptor antagonist drugs.
Du Buske LM
J Allergy Clin Immunol; 1996 Dec; 98(6 Pt 3):S307-18. PubMed ID: 8977542
[TBL] [Abstract][Full Text] [Related]
7. CSACI position statement: Newer generation H
Fein MN; Fischer DA; O'Keefe AW; Sussman GL
Allergy Asthma Clin Immunol; 2019; 15():61. PubMed ID: 31582993
[TBL] [Abstract][Full Text] [Related]
8. Second-generation antihistamines for the treatment of chronic idiopathic urticaria.
Belsito DV
J Drugs Dermatol; 2010 May; 9(5):503-12. PubMed ID: 20480793
[TBL] [Abstract][Full Text] [Related]
9. Suppression of histamine- and allergen-induced skin reactions: comparison of first- and second-generation antihistamines.
dos Santos RV; Magerl M; Mlynek A; Lima HC
Ann Allergy Asthma Immunol; 2009 Jun; 102(6):495-9. PubMed ID: 19558008
[TBL] [Abstract][Full Text] [Related]
10. Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography.
Tashiro M; Sakurada Y; Iwabuchi K; Mochizuki H; Kato M; Aoki M; Funaki Y; Itoh M; Iwata R; Wong DF; Yanai K
J Clin Pharmacol; 2004 Aug; 44(8):890-900. PubMed ID: 15286093
[TBL] [Abstract][Full Text] [Related]
11. Antihistamines in dermatology.
Greaves MW
Skin Pharmacol Physiol; 2005; 18(5):220-9. PubMed ID: 16015020
[TBL] [Abstract][Full Text] [Related]
12. Antihistamines in urticaria.
Ring J; Brockow K; Ollert M; Engst R
Clin Exp Allergy; 1999 Mar; 29 Suppl 1():31-7. PubMed ID: 10209703
[TBL] [Abstract][Full Text] [Related]
13. Variations among non-sedating antihistamines: are there real differences?
Mattila MJ; Paakkari I
Eur J Clin Pharmacol; 1999 Apr; 55(2):85-93. PubMed ID: 10335901
[TBL] [Abstract][Full Text] [Related]
14. [Oral second generation antihistamines in allergic rhinitis].
Riechelmann H
Laryngorhinootologie; 2005 Jan; 84(1):30-41. PubMed ID: 15647976
[TBL] [Abstract][Full Text] [Related]
15. Brain histamine H1 receptor occupancy of orally administered antihistamines, bepotastine and diphenhydramine, measured by PET with 11C-doxepin.
Tashiro M; Duan X; Kato M; Miyake M; Watanuki S; Ishikawa Y; Funaki Y; Iwata R; Itoh M; Yanai K
Br J Clin Pharmacol; 2008 Jun; 65(6):811-21. PubMed ID: 18410464
[TBL] [Abstract][Full Text] [Related]
16. Second generation H1 - antihistamines interaction with food and alcohol-A systematic review.
Paśko P; Rodacki T; Domagała-Rodacka R; Palimonka K; Marcinkowska M; Owczarek D
Biomed Pharmacother; 2017 Sep; 93():27-39. PubMed ID: 28622592
[TBL] [Abstract][Full Text] [Related]
17. H1-antihistamines and the central nervous system.
Welch MJ; Meltzer EO; Simons FE
Clin Allergy Immunol; 2002; 17():337-88. PubMed ID: 12113223
[TBL] [Abstract][Full Text] [Related]
18. Second-generation H1-antihistamines in chronic urticaria: an evidence-based review.
Kavosh ER; Khan DA
Am J Clin Dermatol; 2011 Dec; 12(6):361-76. PubMed ID: 21967114
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of H1-antihistamines: an update.
Kalpaklioglu F; Baccioglu A
Antiinflamm Antiallergy Agents Med Chem; 2012; 11(3):230-7. PubMed ID: 23173575
[TBL] [Abstract][Full Text] [Related]
20. The efficacy and safety of high-dose nonsedating antihistamines in chronic spontaneous urticaria: a systematic review and meta-analysis of randomized clinical trials.
Xiao X; Xue P; Shi Y; Yao J; Cao W; Zhang L; Zou Z; Zhou S; Wang C; Chen M; Jin R; Li Y; Zheng Q
BMC Pharmacol Toxicol; 2023 Apr; 24(1):23. PubMed ID: 37024900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
